Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report) shares traded up 1.7% during mid-day trading on Wednesday. The company traded as high as $1.24 and last traded at $1.20. Approximately 2,034,234 shares changed hands during mid-day trading, an increase of 2,932% from the average daily volume of 67,097 shares. The stock had previously closed at $1.18.
Cardiol Therapeutics Stock Performance
The company’s 50-day moving average is $1.75 and its 200-day moving average is $1.41.
Cardiol Therapeutics Company Profile
Cardiol Therapeutics Inc is a Canadian clinical-stage biotechnology company focused on developing anti-inflammatory therapies for diseases affecting the heart. The company’s research is centered on conditions in which inflammation can contribute to cardiac injury and impaired heart function, including myocarditis and pericarditis.
Cardiol’s lead investigational product, CardiolRx, is a pharmaceutical-grade oral cannabidiol formulation being evaluated as a potential treatment for acute myocarditis and recurrent pericarditis.
Further Reading
- Five stocks we like better than Cardiol Therapeutics
- Tesla Wants to Make Its Own Chips—What Could Go Wrong?
- IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver?
- PBF Energy’s Stunning Rally Faces a Critical Test
- Citi Stock Falls Despite Earnings Beat: What Investors Need to Know
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
